TRIPS flexibilities under threat from investment disputes: a closer look at Canada’s “win” against Eli Lilly


Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.

Post a comment

Who are you?
Your post
  • To create paragraphs, just leave blank lines.